These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26112508)

  • 1. [Hemolytic uremic syndrome in children].
    Cloarec S; Prat L; Merieau E; Benoit S; Halimi JM
    Arch Pediatr; 2015 May; 22(5 Suppl 1):32-3. PubMed ID: 26112508
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful discontinuation of eculizumab therapy in a patient with aHUS.
    Pu JJ; Sido A
    Ann Hematol; 2014 Aug; 93(8):1423-5. PubMed ID: 24346709
    [No Abstract]   [Full Text] [Related]  

  • 3. Eculizumab as first-line therapy for atypical hemolytic uremic syndrome.
    Christmann M; Hansen M; Bergmann C; Schwabe D; Brand J; Schneider W
    Pediatrics; 2014 Jun; 133(6):e1759-63. PubMed ID: 24843059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.
    Cañigral C; Moscardó F; Castro C; Pajares A; Lancharro A; Solves P; de la Rubia J; Carpio N; Sanz MA
    Ann Hematol; 2014 Aug; 93(8):1421-2. PubMed ID: 24306089
    [No Abstract]   [Full Text] [Related]  

  • 5. Understanding thrombotic microangiopathies in children.
    Joly BS; Zheng XL; Veyradier A
    Intensive Care Med; 2018 Sep; 44(9):1536-1538. PubMed ID: 29368057
    [No Abstract]   [Full Text] [Related]  

  • 6. [Eculizumab: effectiveness of a shortened dosing schedule in the treatment of atypical haemolytic uremic syndrome of unknown origin].
    Beye F; Malbranche C; Tramecon D; Pernot C; Zanetta G; Mousson C; Guignard MH; Lazzarotti A
    Therapie; 2013; 68(2):119-22. PubMed ID: 23773354
    [No Abstract]   [Full Text] [Related]  

  • 7. Purtscher-Like Retinopathy in Hemolytic Uremic Syndrome.
    Stroh I; Nguyen A; Channa R
    JAMA Ophthalmol; 2019 Jan; 137(1):e183911. PubMed ID: 30629118
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical grand rounds: atypical hemolytic uremic syndrome.
    Hodgkins KS; Bobrowski AE; Lane JC; Langman CB
    Am J Nephrol; 2012; 35(5):394-400. PubMed ID: 22517061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Eculizumab for atypical hemolytic uremic syndrome in newborn: a case report].
    Alonso-Triana YM; Perrino MJ
    Farm Hosp; 2015 Jul; 39(4):217-8. PubMed ID: 26276740
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of the postpartum atypical hemolytic uremic syndrome with eculizumab.
    Zschiedrich S; Prager EP; Kuehn EW
    Ann Intern Med; 2013 Jul; 159(1):76. PubMed ID: 23817717
    [No Abstract]   [Full Text] [Related]  

  • 11. Eculizumab for the treatment of two recurrences of atypical hemolytic uremic syndrome in a kidney allograft.
    Alachkar N; Bagnasco SM; Montgomery RA
    Transpl Int; 2012 Aug; 25(8):e93-5. PubMed ID: 22591029
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hemolytic uremic syndrome as of 2013].
    Loirat C; Mariani-Kurkdjian P; Fremeaux-Bacchi V
    Arch Pediatr; 2013 Aug; 20(8):827-30. PubMed ID: 23835098
    [No Abstract]   [Full Text] [Related]  

  • 13. Response to Eculizumab in Escherichia coli O157: H7-induced hemolytic uremic syndrome with severe neurological manifestations.
    Saini A; Emke AR; Silva MC; Perlman SJ
    Clin Pediatr (Phila); 2015 Apr; 54(4):387-9. PubMed ID: 24817079
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of eculizumab in the treatment of recurrent atypical hemolytic-uremic syndrome after renal transplantation.
    Larrea CF; Cofan F; Oppenheimer F; Campistol JM; Escolar G; Lozano M
    Transplantation; 2010 Apr; 89(7):903-4. PubMed ID: 20386298
    [No Abstract]   [Full Text] [Related]  

  • 15. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome.
    Diamante Chiodini B; Davin JC; Corazza F; Khaldi K; Dahan K; Ismaili K; Adams B
    Pediatrics; 2014 Jun; 133(6):e1764-8. PubMed ID: 24843055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hemolytic-uremic syndrome.
    McCredie DA; Dixon SR
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1069-78. PubMed ID: 4803304
    [No Abstract]   [Full Text] [Related]  

  • 17. Cryptic activity of atypical hemolytic uremic syndrome and eculizumab treatment.
    Belingheri M; Possenti I; Tel F; Paglialonga F; Testa S; Salardi S; Ardissino G
    Pediatrics; 2014 Jun; 133(6):e1769-71. PubMed ID: 24843058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical hemolytic uremic syndrome: from the rediscovery of complement to targeted therapy.
    Fakhouri F; Frémeaux-Bacchi V; Loirat C
    Eur J Intern Med; 2013 Sep; 24(6):492-5. PubMed ID: 23756030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current aspects of hemolytic uremic syndrome in children].
    Brumariu O; Cucer F; Munteanu M
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):253-60. PubMed ID: 14755925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemolytic and uremic syndrome in children].
    Kamoun T; Djemal N; Ellouz M; Aloulou H; Chaabouni M; Mahfoudh A; Hachicha M
    Tunis Med; 2008 Jul; 86(7):715-7. PubMed ID: 19472740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.